BackIntersect ENT Overview

Intersect ENT Receivables

Intersect ENT's receivables is $13M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$13.24M
↓ 9.22% YoYΔ $-1.34M vs prior year quarter

Peer trimmed avg / median

Loading

Intersect ENT Receivables History

Loading

Intersect ENT vs. peers: Receivables Comparison

Loading

Intersect ENT Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Intersect ENT (XENT) FAQ

As of the most recent data (March 2022), XENT shows a receivables of $13M. That compares with $15M in the prior-year period — down 9.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, XENT's receivables is now $13M (was $15M) — a 9.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Intersect ENT is outperforming or lagging.

Tracking XENT's receivables over time shows whether Intersect ENT is scaling, shrinking, or reshaping that part of the business. The current reading is $13M That compares with $15M in the prior-year period — down 9.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Intersect ENT's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $13M) with ownership activity and broader fundamentals.

Intersect ENT's receivables is $13M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.